Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

By 2028, Demand for Global Clinical Nutrition Market Size & Share Will Surpass USD 45,887.4 Million Mark, at 5.8% CAGR Growth | Industry Trends, Value, Analysis & Forecast Report by Zion Market Research


NEW YORK, May 16, 2022 /PRNewswire/ -- As per Zion Market Research study, The Clinical Nutrition Market was worth around USD 32,717.5 million in 2021 and is estimated to grow to about USD 45,887.4 million by 2028, with a compound annual growth rate (CAGR) of approximately 5.8 percent over the forecast period. The report analyzes the Clinical Nutrition Market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the Clinical Nutrition Market.

Zion_Market_Research_Logo

Key Industry Insights & Finding of the Clinical Nutrition Market Reports:

Zion Market Research published the latest report titled as  "Clinical Nutrition Market By Route of Administration (Oral, Enteral, and Parenteral). By Application (Cancer, Neurological Diseases, Metabolic Disorders, and Others). By End User (Pediatric, Adults, and Geriatric). and By Region ? Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 ? 2028" into their research database.

Clinical Nutrition Market: Overview

Clinical nutrition assists in the prevention of diet-related disorders by detecting and treating diseases that affect food intake, intestinal absorption, and metabolism. The increasing prevalence of metabolic disorders, increased healthcare spending, and the development of the middle class in emerging economies are all driving the clinical nutrition industry ahead. The expanding aged population, as well as the development of therapeutic nutrition products tailored to the aging population, are projected to drive market expansion. COVID-19 infection has become a serious public health concern, and clinical nutrition plays a critical role in infection prevention and treatment of infection-related malnutrition. The rising prevalence of chronic diseases such as cancer and cardiovascular problems, malnutrition, respiratory diseases, and gastrointestinal ailments among children and adults is contributing to an increase in the demand for nutritional assistance. Furthermore, the growing demand for clinical nutrition in pediatric care is shaping up to be a promising potential for the clinical nutrition market. Clinical nutrition is vital during surgeries since it helps to reduce any harmful effects on patients while also allowing surgeons to work in a controlled environment. The clinical nutrition market is expected to rise throughout the projected period as a consequence of the increased sickness burden and surgery volume. 

Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.zionmarketresearch.com/sample/clinical-nutrition-market

Our Free Sample Report Includes:

Industry Dynamics:

Clinical Nutrition Market: Growth Dynamics

Drivers:  

The growing number of people globally suffering from chronic diseases like as diabetes and cancer, together with the significant growth in the elderly population, will fuel the clinical nutrition market's expansion in the coming years. Since patients suffering from chronic disorders have a deficiency in important nutrients, the rise in chronic disorders has necessitated the use of clinical nutrition prescriptions. Furthermore, the growing obese population base as a result of poor eating habits and a lack of exercise can accelerate clinical nutrition market expansion. Elderly persons frequently lose their appetites or have digestive problems, necessitating nutrient supplementation via enteral or parenteral routes. This feature is expected to benefit the worldwide clinical nutrition industry over the next few years. Additionally, the large growth in premature births, as well as the overall high birth rate around the world, may boost the global industry. Premature death rates have decreased as a result of increased awareness and well-equipped facilities, resulting in significant market growth.

Restraints:

Stringent restrictions and reimbursement concerns are projected to stymie market growth. Clinical nutrition items are classified as pharmaceuticals. As a result, producers must adhere to certain rules and regulations established by regulatory authorities such as the Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Enteral products are similar to medications. As a result, they do need to go through extensive clinical trials for safety and efficacy approvals before they can be sold. Enteral nutrition products are subject to stringent labeling regulations, which include thorough supplement facts boxes. This is projected to limit the market's growth. Moreover, a lack of understanding of clinical nutrition in emerging nations is projected to impede market expansion.

Directly Purchase a Copy of the Report @ https://www.zionmarketresearch.com/buynow/su/clinical-nutrition-market

Global Clinical Nutrition Market: Segmentation

By Route of Administration, the market is categorized into Oral, Enteral, and Parenteral. The oral clinical nutrition market held the largest share during the forecast period and is expected to maintain its dominance throughout the forecast period, owing to an increase in malnourished patients with malignancy, chronic disease, and/or anorexia, as well as an increase in the incidences of chronic diseases such as cancer, gastrointestinal disorders, and metabolic disorders, all of which provide lucrative growth opportunities for the oral clinical nutrition market.

By Application, the market is classified into Cancer, Neurological Diseases, Metabolic Disorders, and Others. The cancer segment is expected to have the highest growth rate during the forecast period, owing to an increase in the number of people suffering from chronic conditions such as cancer and diabetes, as well as a growing geriatric population base, which is expected to drive the market over the forecast timeframe. The rising prevalence of chronic diseases has prompted an increase in clinical nutrition prescriptions, as patients suffering from such ailments are deficient in a number of critical nutrients. Furthermore, the growing obese population as a result of poor food habits and physical inactivity will drive business growth.

Get More Insight before Buying@ : https://www.zionmarketresearch.com/inquiry/clinical-nutrition-market

List of Key Players of  Clinical Nutrition Market:

Key questions answered in this report:

Report Scope:

Report Attribute

Details

Market size value in 2021

USD 32,717.5 Million

Revenue forecast in 2028

USD 45,887.4 Million

Growth Rate

CAGR of almost 5.8 % 2022-2028

Base Year

2020

Historic Years

2016 - 2021

Forecast Years

2022 - 2028

Segments Covered

By Product Type, By Application, and By End Use

Forecast Units

Value (USD Million), and Volume (Units)

Quantitative Units

Revenue in USD million/billion and CAGR from 2022 to 2028

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others

Companies Covered

Abbott Laboratories, B. Braun Melsugen AG, Danone Nutricia Baxter Internatioinal Inc., Fresenius SE & Co. KGaA, Perrigo Company Plc, Pfizer Inc., Lonza Ltd, Nestle S.A., and Hero Nutritionals Inc.

Report Coverage

Market growth drivers, restraints, opportunities, Porter's five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.

Customization Scope

Avail customized purchase options to meet your exact research needs.  

https://www.zionmarketresearch.com/custom/2680

 Free Brochure: https://www.zionmarketresearch.com/requestbrochure/clinical-nutrition-market

Recent Developments:

Regional Dominance:

During the forecast period, APAC has been the clinical nutrition industry leader, with Japan emerging as the region's top performer. The Japanese market is leading due to a growing older population and an increase in chronic diseases such as cancer and diabetes mellitus as a result of dietary changes. Increased efforts by organizations such as the Japan Society of Nutrition and Food Science (JSNFS) to improve public health and raise awareness of clinical nutrition may potentially benefit market growth in Japan over the assessment period. The clinical nutrition market in China benefits most from an increase in the number of players entering the nation and an increase in the number of cases of metabolic diseases.

North America held a significant position in the worldwide clinical nutrition market during the forecast period. The United States is presently in the lead, and the country-based market could improve its position in the next years as a result of high consumer awareness about wellness and health, as well as the growing desire to reduce considerable healthcare expenses. The region's clinical nutrition market demand is also being boosted by the region's rising birth rate. The growing senior population has resulted in a major increase in demand for home healthcare over the years, which is likely to be a primary growth booster in the coming years.

Global Clinical Nutrition Market is segmented as follows:

Clinical Nutrition Market: By Route of Administration Outlook (2022-2028)

Clinical Nutrition Market: By Application Outlook (2022-2028)

Clinical Nutrition Market: By End User Outlook (2022-2028)

Clinical Nutrition Market: By Region Outlook (2022-2028)

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Press Release For Clinical Nutrition Market: https://www.zionmarketresearch.com/news/global-clinical-nutrition-market

Browse Other Related Research Reports from Zion Market Research

Browse through Zion Market Research's coverage of the Global Pharmaceutical Industry

Follow Us on: LinkedIn | Twitter | Facebook

About Us

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us?after all?if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: [email protected] 
Website: https://www.zionmarketresearch.com/
Blog - https://zmrblog.com/

Logo: https://mma.prnewswire.com/media/1605489/Zion_Market_Research_Logo.jpg


These press releases may also interest you

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...



News published on and distributed by: